N-Power Medicine builds ProECA, a platform that creates prospective, trial-grade external control arms from routine community oncology care data. Its inaugural program in non-small cell lung cancer runs across more than 40 US community oncology sites, with colorectal and prostate programs planned for late 2026. Backers include Labcorp Venture Fund, Merck Global Health Innovation Fund and Innovatus Capital Partners.
1
Round
1
Industry
4
Tags
Sep 1, 2026
Latest raise
Funding activity · 1 round
Sep 1, 2026
$32M
Series B
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
